Orchid Pharma Appoints Arjun Dhanuka as Whole-Time Director, Schedules 33rd AGM

Orchid Pharma Limited announced a significant outcome from its Board Meeting held on September 03, 2026. The Board approved the appointment and remuneration of the company's Cost Auditors for the Financial Year 2026-27. M/s. J Karthikeyan & Associates, Cost Accountants from Chennai, have been appointed, subject to member ratification at the upcoming AGM.

Furthermore, the Board approved the appointment of Mr. Arjun Dhanuka (DIN: 00454689) as a Whole-Time Director. Mr. Dhanuka, who previously served as a Non-Executive Non-Independent Director, will hold this position from September 03, 2026, to September 02, 2031. He brings over a decade of experience in the Pharmaceuticals Sector, having worked with Dhanuka Laboratories Limited and Synmedic Laboratories, focusing on purchase decisions, operations, and business development.

The company also announced the convening of its 33rd Annual General Meeting (AGM) scheduled for September 29, 2026. The cut-off date for determining eligible shareholders for the AGM notice and e-voting is set for Friday, September 04, 2026. The remote e-voting period will run from September 26, 2026, 9:00 AM IST, to September 28, 2026, 5:00 PM IST. An e-voting agency and a scrutinizer have been appointed to facilitate the process.